Value of the radiotracer 99mTc-MIP-1404 and of the Anger camera VeritonCZT in patients with prostate cancer.
Phase 1
- Conditions
- Prostate cancer. Please see the study protocol.Therapeutic area: Diseases [C] - Male diseases of the urinary and reproductive systems [C12]
- Registration Number
- EUCTR2021-001059-15-SE
- Lead Sponsor
- Fysiologiska Kliniken, Linköping US
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- Male
- Target Recruitment
- 250
Inclusion Criteria
Please see the study protocol
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 50
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 200
Exclusion Criteria
Please see the study protocol´s inklusion och exklusionskriterier
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Please see the study protocol;Secondary Objective: Not applicable;Primary end point(s): Please see the study protocol´s endpoint;Timepoint(s) of evaluation of this end point: Please see the study protocol´s tidtabell
- Secondary Outcome Measures
Name Time Method Secondary end point(s): Not applicable;Timepoint(s) of evaluation of this end point: Not applicable